Find A Portfolio/Ticker
Comparison Box
PPH: Market Vectors Pharmaceutical ETF (ETF)
Basic Info 78.32 0.87(1.12%) February 07
Asset Class: | Health |
MyPlanIQ Rating: | (93%) |
Start Date: | 02/01/2000 |
Last Dividend Date: | 12/28/2022 |
12-Mo. Yield | 1.65% |
Expenses | 0.35% |
Sign up to get fund ranking change alerts |
Performance Analytics (As of 02/03/2023)
Not up-to-date? TryLast 1 Week* | YTD*(2023) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | Inception** | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AR(%) | -0.0 | 0.7 | 6.7 | 8.0 | 8.3 | 8.6 | 8.3 | 5.4 | 3.9 | 18.8 | 5.5 | 19.4 | -5.9 | 15.2 | -17.8 | 3.5 | 23.2 | 36.7 | 13.1 | 16.8 | 1.9 | 18.2 | -19.7 | 5.8 | 15.8 | -1.8 | -6.3 | 9.6 | -23.3 | -12.6 | 30.8 |
SR | NA | -0.69 | 0.19 | 0.4 | 0.34 | 0.46 | NA | 0.23 | 0.15 | 1.54 | 0.18 | 1.25 | -0.41 | 1.25 | -0.98 | 0.2 | 1.68 | 3.39 | 1.2 | 0.93 | 0.13 | 0.92 | -0.68 | 0.21 | 1.13 | -0.33 | -0.49 | 0.47 | -0.85 | -0.7 | 0.98 |
DD(%) | NA | 2.8 | 20.0 | 29.7 | 29.7 | 30.2 | NA | 46.4 | 20.0 | 7.1 | 29.7 | 10.6 | 18.4 | 9.8 | 20.8 | 17.5 | 9.0 | 6.4 | 7.7 | 14.5 | 15.3 | 19.7 | 33.9 | 10.2 | 6.9 | 11.7 | 18.8 | 14.2 | 39.5 | 22.4 | 21.6 |
SD(%) | NA | 11.7 | 17.4 | 20.9 | 19.0 | 17.1 | NA | 18.7 | 17.5 | 12.2 | 29.4 | 14.4 | 17.4 | 11.7 | 18.3 | 17.4 | 13.8 | 10.8 | 11.0 | 18.0 | 14.1 | 19.7 | 30.2 | 13.1 | 11.1 | 12.1 | 14.6 | 19.0 | 28.7 | 21.7 | 30.4 |
TR | NA | -0.1 | 0.04 | 0.09 | 0.07 | 0.08 | NA | 0.04 | 0.03 | 0.28 | 0.05 | 0.19 | -0.07 | 0.16 | -0.17 | 0.04 | 0.24 | 0.4 | 0.13 | 0.18 | 0.02 | 0.19 | -0.21 | 0.03 | 0.13 | -0.04 | -0.06 | 0.07 | -0.19 | -0.14 | 0.26 |
Alpha(%) | NA | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | NA | -0.02 | 0.01 | 0.02 | -0.02 | -0.01 | -0.02 | 0.01 | -0.04 | -0.03 | -0.01 | -0.01 | -0.01 | 0.02 | -0.02 | 0.0 | -0.01 | 0.01 | 0.02 | -0.06 | -0.06 | -0.07 | -0.04 | -0.02 | -0.08 |
Beta(%) | NA | 0.81 | 0.75 | 0.89 | 0.91 | 0.93 | NA | 1.0 | 0.75 | 0.68 | 1.02 | 0.95 | 1.01 | 0.91 | 1.04 | 0.98 | 0.97 | 0.92 | 1.0 | 0.94 | 1.0 | 0.95 | 0.97 | 1.07 | 0.95 | 1.04 | 1.12 | 1.21 | 1.3 | 1.11 | 1.17 |
RS | NA | 0.58 | 0.76 | 0.81 | 0.81 | 0.81 | NA | 0.75 | 0.75 | 0.55 | 0.92 | 0.79 | 0.84 | 0.59 | 0.84 | 0.89 | 0.84 | 0.79 | 0.82 | 0.89 | 0.84 | 0.78 | 0.85 | 0.78 | 0.63 | 0.54 | 0.59 | 0.79 | 0.83 | 0.62 | 0.47 |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 02/01/2000
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (Vanguard Health Care Inv) 0.73% (97%)
- HGHAX (Hartford Healthcare A) 0.81% (77%)
- FSMEX (Fidelity Select Medical Equip & Systems) 1.22% (76%)
- FBIOX (Fidelity Select Biotechnology) 0.54% (76%)
- FBTIX (Fidelity Advisor Biotechnology I) 0.33% (76%)
- FSHCX (Fidelity Select Medical Delivery Port) 0.86% (73%)
- FSPHX (Fidelity Select Health Care) 1.10% (73%)
- FHCIX (Fidelity Advisor Health Care I) 1.09% (72%)
- SHSSX (BlackRock Health Sciences Opps Inst) 0.71% (65%)
- MEDRX (Kinetics Medical No Load) 0.0% (65%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR ETF) 0.64% (96%)
- BBH (Market Vectors Biotech ETF) 0.67% (94%)
- IBB (iShares Nasdaq Biotechnology) 0.52% (94%)
- PPH (Market Vectors Pharmaceutical ETF) 1.12% (93%)
- FBT (First Trust NYSE Arca Biotech ETF) 0.85% (91%)
- FXH (First Trust Health Care AlphaDEX ETF) 0.88% (90%)
- IHE (iShares US Pharmaceuticals) 0.71% (88%)
- IHF (iShares US Healthcare Providers) 0.72% (87%)
- IHI (iShares US Medical Devices) 1.37% (87%)
Best Closed End Funds
- BME (BlackRock Health Sciences) 0.63% (100%)
- GRX (Gabelli Healthcare & Wellness Trust) 1.64% (99%)
- HQH (H&Q Healthcare Investors) 0.32% (98%)
- HQL (H&Q Life Sciences Investors) 0.54% (98%)